By 2026, a drug will be available that can extend the life of dogs (3 photos)

Many are ready to pay any amount of money to make their pet live a few more years, and such an opportunity will appear very soon. American biotech company Loyal has created a drug called LOY-001, which can extend the life of large breed dogs.





According to Loyal's research, the larger the dog, the shorter its life expectancy: large breeds live on average from 7 to 10 years, while small breeds live from 14 to 16 years.



After four years of FDA testing, Loyal found that the drug “improves clinically relevant parameters of aging,” suggesting that it may help extend the lifespan of large breed dogs.

LOY-001 targets and significantly reduces levels of the hormone IGF-1, which accelerates the aging process.



The drug will be administered by a veterinarian every three to six months, and according to Celine Halioua, founder of Loyal, it may be especially beneficial for older dogs.

She explained, “Each milestone we’ve reached in this methodical, evidence-based process has shown us steady progress toward our goal of helping dogs live longer, healthier lives. With FDA approval, we’ll be able to bring our products into veterinary clinics and usher in a new approach to combating age-related diseases. Ultimately, this means our beloved dogs will live longer. That’s our goal.”